investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors
Hiroaki Mitsuya
4 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Yasuhiro Koh
Kumamoto University
Kumamoto, Japan
Masayuki Amano
Kumamoto University
Kumamoto, Japan
Hiromi Ogata-Aoki
Kumamoto University
Kumamoto, Japan
Hiroanori Hayashi
Kumamoto University
Kumamoto, Japan
Hiroaki Mitsuya
National Cancer Institute (NIH)
Rockville, United States
Related projects
Jian-Yue Jin
A Synchronized Moving Grid (SMOG) System to Improve CBCT for IGRT and ART
All cancers but non-melanoma skin cancer
Peter Blumberg
Molecular Mechanism of Action of Phorbol Ester – Rockville
All cancers but non-melanoma skin cancer
Romina Goldszmid
Role of the microbiota in regulating the mononuclear phagocyte system
All cancers but non-melanoma skin cancer
David Waugh
Protein Expression and Purification in the Fast Lane
All cancers but non-melanoma skin cancer
Christine Mayr
Dissecting the role of alternative 3UTRs in cancer with 3-seq
All cancers but non-melanoma skin cancer
Pathology
Gerald R. Crabtree
ATP-Dependent Chromatin Remodeling in Human Malignancy
All cancers but non-melanoma skin cancer
Paul J. Anderson
Angiogenin-Induced RNA Cleavage in Cancer
All cancers but non-melanoma skin cancer
George Pavlakis
DNA Vaccines
All cancers but non-melanoma skin cancer
Pathology
Alexander Gimelbrant
(PQD4) Epigenetic loss of heterozygosity as a driver of the cancer field effect
All cancers but non-melanoma skin cancer